Clinical and bacteriological implications of macrolide resistance in group A streptococcal pharyngitis [5]

Journal of Antimicrobial Chemotherapy

Volumn 52, Issue 4, 2003, Pages 735-736

  Martin Herrero, Jose E ^a   Garcia Rey, Cesar ^a   Dal Ré, Rafael ^a   Aguillar, Lorenzo ^a  

^a GLAXOSMITHKLINE   (Spain)

Author keywords

Clarithromycin; Macrolides; Penicillin; Resistance; Streptococcus pyogenes

Indexed keywords

ANTIBIOTIC AGENT; BETA LACTAM ANTIBIOTIC; CLARITHROMYCIN; MACROLIDE; PENICILLIN V;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; BACTERIAL STRAIN; CLINICAL PRACTICE; CLINICAL STUDY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; HUMAN; LETTER; MAJOR CLINICAL STUDY; MULTICENTER STUDY; NONHUMAN; PHARYNGITIS; STATISTICAL SIGNIFICANCE; STREPTOCOCCUS GROUP A; TREATMENT FAILURE; TREATMENT OUTCOME;

DRUG RESISTANCE, BACTERIAL; HUMANS; MACROLIDES; PHARYNGITIS; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS PYOGENES;

EID: 0141893627     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/dkg414     Document Type: Letter

References (3)

1. Portier, H., Filipecki, J., Weber, P. et al. (2002). Five day clarithromycin modified release versus 10 day penicillin V for group A streptococcal pharyngitis: a multi-centre, open-label, randomized study. Journal of Antimicrobial Chemotherapy 49, 337-44.
2. Pérez-Trallero, E., Fernández-Mazarrasa, C., García-Rey, C. et al. (2001). Antimicrobial susceptibilities of 1,684 Streptococcus pneumoniae and 2,039 Streptococcus pyogenes isolates and their ecological relationships: Results of a 1-year (1998-1999) multicenter surveillance study in Spain. Antimicrobial Agents and Chemotherapy 45, 3334-40.
3. Facinelli, B., Spinaci, C., Magi, G. et al. (2001). Association between erythromycin resistance and ability to enter human respiratory cells in group A streptococci. Lancet 358, 30-3.